Michael Bishop to Immunotherapy
This is a "connection" page, showing publications Michael Bishop has written about Immunotherapy.
Connection Strength
1.147
-
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma. J Immunother Cancer. 2020 12; 8(2).
Score: 0.465
-
Monoclonal antibody therapy. Front Biosci. 2006 May 01; 11:1620-35.
Score: 0.169
-
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC). J Immunother Cancer. 2022 09; 10(9).
Score: 0.131
-
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events. J Immunother Cancer. 2020 12; 8(2).
Score: 0.116
-
The case for CAR T-cell therapy in follicular lymphomas. Blood. 2019 08 15; 134(7):577-578.
Score: 0.106
-
Prevention and treatment of relapse after stem cell transplantation with immunotherapy. Bone Marrow Transplant. 2018 06; 53(6):664-672.
Score: 0.098
-
Immunotherapy for breast cancer. Cancer Chemother Biol Response Modif. 2002; 20:351-69.
Score: 0.031
-
Management of hemophagocytic lymphohistiocytosis (HLH) associated with chimeric antigen receptor T-cell (CAR-T) therapy using anti-cytokine therapy: an illustrative case and review of the literature. Leuk Lymphoma. 2021 07; 62(7):1765-1769.
Score: 0.029